SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about disclosure

09 Jan 2020 Evaluate

Strides Pharma Science has informed that R Ananthanarayanan, Chief Executive Officer and Managing Director of the Company, is also appointed as Key Managerial Personnel of the Company effective January 9, 2020. Accordingly, in terms of SEBI Listing Regulations, he is also authorized to determine materiality of an event or information and to make disclosures to Stock Exchanges as required under the said Regulation.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1110.55 -15.70 (-1.39%)
08-Jul-2026 10:13 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1907.95
Dr. Reddys Labs. 1366.00
Cipla 1455.00
Zydus Lifesciences 1170.55
Lupin 2510.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: